{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:23:13Z","timestamp":1785032593802,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015034","name":"Shahid Sadoughi University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18582-x","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:18:48Z","timestamp":1759159128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of anti-thyroid peroxidase antibodies among women with polycystic ovary syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Zahra","family":"Rasoulizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Eftekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Ghadiri-Anari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Akbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Soleimanizad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Emarati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Ordooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"18582_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"Sirmans, S. M. & Pate, K. A. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin. Epidemiol. 6, 1\u201313 (2013).","journal-title":"Clin. Epidemiol."},{"key":"18582_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic, D. A. et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr. Rev. 36, 487\u2013525 (2015).","journal-title":"Endocr. Rev."},{"key":"18582_CR3","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman, N. F. et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014Part 1. Endocr. Pract. 21, 1291\u20131300 (2015).","journal-title":"Endocr. Pract."},{"key":"18582_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41\u201347 (2004).","journal-title":"Hum. Reprod."},{"key":"18582_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/jcm11061547","volume":"11","author":"IM Gawron","year":"2022","unstructured":"Gawron, I. M., Baran, R., Derbisz, K. & Jach, R. Association of subclinical hypothyroidism with present and absent anti-thyroid antibodies with PCOS phenotypes and metabolic profile. J. Clin. Med. 11, 6 (2022).","journal-title":"J. Clin. Med."},{"key":"18582_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3109\/07435800.2015.1015730","volume":"40","author":"A Arduc","year":"2015","unstructured":"Arduc, A. et al. High prevalence of Hashimoto\u2019s thyroiditis in patients with polycystic ovary syndrome: Does the imbalance between estradiol and progesterone play a role?. Endocr. Res. 40, 204\u2013210 (2015).","journal-title":"Endocr. Res."},{"key":"18582_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/14647273.2019.1709668","volume":"25","author":"JJ Kim","year":"2022","unstructured":"Kim, J. J. et al. Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls. Hum. Fertil. 25, 128\u2013134 (2022).","journal-title":"Hum. Fertil."},{"key":"18582_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tjog.2023.10.003","volume":"63","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny, S. S., Bastani, M. N., Aghaei, M., Dabbagh, M. R. & Mahdizade, A. H. Circulating galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis. Taiwan. J. Obstet. Gynecol. 63, 37\u201345 (2024).","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"18582_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2024.104215","volume":"163","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny, S. S. et al. Autoimmune thyroid disorders and polycystic ovary syndrome: Tracing links through systematic review and meta-analysis. J. Reprod. Immunol. 163, 104215 (2024).","journal-title":"J. Reprod. Immunol."},{"key":"18582_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12020-014-0504-7","volume":"49","author":"C Duran","year":"2015","unstructured":"Duran, C. et al. Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome. Endocrine 49, 464\u2013469 (2015).","journal-title":"Endocrine"},{"key":"18582_CR11","volume-title":"International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (Version 1)","author":"H Teede","year":"2023","unstructured":"Teede, H. et al. International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (Version 1) (Monash University, 2023)."},{"key":"18582_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejogrb.2013.03.003","volume":"169","author":"S Garelli","year":"2013","unstructured":"Garelli, S. et al. High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 169, 248\u2013251 (2013).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"18582_CR13","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.17954","volume":"12","author":"R Al-Saab","year":"2014","unstructured":"Al-Saab, R. & Haddad, S. Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: A case-control study from Syria. Int. J. Endocrinol. Metab. 12, e17954 (2014).","journal-title":"Int. J. Endocrinol. Metab."},{"key":"18582_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13224-016-0914-y","volume":"67","author":"M Menon","year":"2017","unstructured":"Menon, M. & Ramachandran, V. Antithyroid peroxidase antibodies in women with polycystic ovary syndrome. J. Obstet. Gynaecol. India 67, 61\u201365 (2017).","journal-title":"J. Obstet. Gynaecol. India"},{"key":"18582_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4103\/2230-8210.109714","volume":"17","author":"U Sinha","year":"2013","unstructured":"Sinha, U. et al. Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Indian J. Endocrinol. Metab. 17, 304\u2013309 (2013).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"18582_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/0974-1208.178636","volume":"9","author":"S Arora","year":"2016","unstructured":"Arora, S., Sinha, K., Kolte, S. & Mandal, A. Endocrinal and autoimmune linkage: Evidences from a controlled study of subjects with polycystic ovarian syndrome. J. Hum. Reprod. Sci. 9, 18\u201322 (2016).","journal-title":"J. Hum. Reprod. Sci."},{"key":"18582_CR17","doi-asserted-by":"publisher","first-page":"1470283","DOI":"10.3389\/fimmu.2024.1470283","volume":"15","author":"H Deng","year":"2024","unstructured":"Deng, H., Chen, Y., Xing, J., Zhang, N. & Xu, L. Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome. Front. Immunol. 15, 1470283 (2024).","journal-title":"Front. Immunol."},{"key":"18582_CR18","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1016\/j.fertnstert.2010.05.047","volume":"94","author":"N Raja-Khan","year":"2010","unstructured":"Raja-Khan, N. et al. A variant in the fibrillin-3 gene is associated with TGF-\u03b2 and inhibin B levels in women with polycystic ovary syndrome. Fertil. Steril. 94, 2916\u20132919 (2010).","journal-title":"Fertil. Steril."},{"key":"18582_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.606620","volume":"12","author":"N Zeber-Lubecka","year":"2021","unstructured":"Zeber-Lubecka, N. & Hennig, E. E. Genetic susceptibility to joint occurrence of polycystic ovary syndrome and Hashimoto\u2019s thyroiditis: How far is our understanding?. Front. Immunol. 12, 606620 (2021).","journal-title":"Front. Immunol."},{"key":"18582_CR20","doi-asserted-by":"publisher","first-page":"1578470","DOI":"10.3389\/fimmu.2025.1578470","volume":"16","author":"D Wu","year":"2025","unstructured":"Wu, D. et al. The relationship between polycystic ovary syndrome and gynecological cancers: Neurotransmitter metabolism changes and immune regulation. Front. Immunol. 16, 1578470 (2025).","journal-title":"Front. Immunol."},{"key":"18582_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4049\/immunohorizons.2200033","volume":"7","author":"S Banerjee","year":"2023","unstructured":"Banerjee, S., Cooney, L. G. & Stanic, A. K. Immune dysfunction in polycystic ovary syndrome. Immunohorizons 7, 323\u2013332 (2023).","journal-title":"Immunohorizons"},{"key":"18582_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12902-019-0370-7","volume":"19","author":"S Bahri","year":"2019","unstructured":"Bahri, S. et al. Overtime trend of thyroid hormones and thyroid autoimmunity and ovarian reserve: A longitudinal population study with a 12-year follow up. BMC Endocr. Disord. 19, 47 (2019).","journal-title":"BMC Endocr. Disord."},{"key":"18582_CR23","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.fertnstert.2010.05.063","volume":"94","author":"J Ott","year":"2010","unstructured":"Ott, J. et al. Elevated antithyroid peroxidase antibodies indicating Hashimoto\u2019s thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome. Fertil. Steril. 94, 2895\u20132897 (2010).","journal-title":"Fertil. Steril."},{"key":"18582_CR24","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1089\/thy.2017.0139","volume":"27","author":"CW Chen","year":"2017","unstructured":"Chen, C. W., Huang, Y. L., Tzeng, C. R., Huang, R. L. & Chen, C. H. Idiopathic low ovarian reserve is associated with more frequent positive thyroid peroxidase antibodies. Thyroid 27, 1194\u20131200 (2017).","journal-title":"Thyroid"},{"key":"18582_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly, D. et al. The physiology and clinical utility of anti-M\u00fcllerian hormone in women. Hum. Reprod. Update 20, 370\u2013385 (2014).","journal-title":"Hum. Reprod. Update"},{"key":"18582_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/endrev\/bnab012","volume":"42","author":"N di Clemente","year":"2021","unstructured":"di Clemente, N., Racine, C., Pierre, A. & Taieb, J. Anti-M\u00fcllerian hormone in female reproduction. Endocr. Rev. 42, 753\u2013782 (2021).","journal-title":"Endocr. Rev."},{"key":"18582_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12902-021-00706-9","volume":"21","author":"AN Serin","year":"2021","unstructured":"Serin, A. N., Birge, \u00d6., Uysal, A., G\u00f6rar, S. & Tekeli, F. Hashimoto\u2019s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to anti-M\u00fcllerian hormone levels. BMC Endocr. Disord. 21, 44 (2021).","journal-title":"BMC Endocr. Disord."},{"key":"18582_CR28","doi-asserted-by":"crossref","unstructured":"Jaroudi, S., Gavin, M., Boylan, K. & Peiris, A. N. Transient T3 toxicosis associated with Hashimoto\u2019s disease. Proc. (Bayl Univ. Med. Cent) 32, 80\u201381 (2019).","DOI":"10.1080\/08998280.2018.1503480"},{"key":"18582_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1210\/clinem\/dgac635","volume":"108","author":"SS Praw","year":"2022","unstructured":"Praw, S. S. & Brent, G. A. Approach to the patient with a suppressed TSH. J. Clin. Endocrinol. Metab. 108, 472\u2013482 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"18582_CR30","first-page":"948","volume":"93","author":"K Skrzynska","year":"2022","unstructured":"Skrzynska, K., Zachurzok, A., Tomaszewski, R., Gawlik, A. & Malecka-Tendera, E. The prevalence of autoimmune thyroiditis in adolescent girls with polycystic ovary syndrome. Ginekol. Pol. 93, 948\u2013953 (2022).","journal-title":"Ginekol. Pol."},{"key":"18582_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5507\/bp.2014.062","volume":"159","author":"J Petrikova","year":"2015","unstructured":"Petrikova, J. et al. The prevalence of non organ specific and thyroid autoimmunity in patients with polycystic ovary syndrome. Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub. 159, 302\u2013306 (2015).","journal-title":"Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18582-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18582-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18582-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:18:49Z","timestamp":1759159129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18582-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18582"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18582-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee of Shahid Sadoughi University of Medical Sciences, Yazd, Iran (Ethical certificate code: IR.SSU.REC.1402.144). Written informed consent was obtained from all participants prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"33563"}}